Allianz Asset Management’s Inovio Pharmaceuticals INO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-4,175
| Closed | -$582K | – | 1871 |
|
|
2020
Q3 | $582K | Sell |
4,175
-408
| -9% | -$56.9K | ﹤0.01% | 1543 |
|
|
2020
Q2 | $1.48M | Buy |
+4,583
| New | +$1.48M | ﹤0.01% | 1343 |
|
|
2018
Q3 | – | Sell |
-17,913
| Closed | -$843K | – | 2143 |
|
|
2018
Q2 | $843K | Sell |
17,913
-104
| -0.6% | -$4.89K | ﹤0.01% | 1781 |
|
|
2018
Q1 | $1.02M | Sell |
18,017
-305
| -2% | -$17.2K | ﹤0.01% | 1716 |
|
|
2017
Q4 | $908K | Sell |
18,322
-242
| -1% | -$12K | ﹤0.01% | 1757 |
|
|
2017
Q3 | $1.41M | Buy |
18,564
+2,054
| +12% | +$156K | ﹤0.01% | 1600 |
|
|
2017
Q2 | $1.55M | Buy |
16,510
+935
| +6% | +$88K | ﹤0.01% | 1554 |
|
|
2017
Q1 | $1.24M | Buy |
15,575
+4,359
| +39% | +$346K | ﹤0.01% | 1657 |
|
|
2016
Q4 | $934K | Sell |
11,216
-1,466
| -12% | -$122K | ﹤0.01% | 1709 |
|
|
2016
Q3 | $1.42M | Buy |
12,682
+1,311
| +12% | +$147K | ﹤0.01% | 1593 |
|
|
2016
Q2 | $1.26M | Buy |
+11,371
| New | +$1.26M | ﹤0.01% | 1578 |
|